| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 64 | 2024 | 991 | 5.100 |
Why?
|
| CpG Islands | 36 | 2024 | 321 | 3.300 |
Why?
|
| Epigenesis, Genetic | 21 | 2024 | 666 | 2.570 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 7 | 2024 | 101 | 1.900 |
Why?
|
| Carcinogenesis | 4 | 2024 | 332 | 1.680 |
Why?
|
| Colorectal Neoplasms | 16 | 2023 | 559 | 1.600 |
Why?
|
| Colonic Neoplasms | 9 | 2023 | 247 | 1.390 |
Why?
|
| Promoter Regions, Genetic | 17 | 2015 | 1354 | 0.950 |
Why?
|
| Gene Silencing | 13 | 2012 | 236 | 0.940 |
Why?
|
| Intestinal Neoplasms | 1 | 2024 | 40 | 0.890 |
Why?
|
| Gene Expression Regulation, Neoplastic | 17 | 2024 | 1890 | 0.810 |
Why?
|
| DNA | 5 | 2021 | 1608 | 0.760 |
Why?
|
| Embryonic Stem Cells | 4 | 2013 | 172 | 0.620 |
Why?
|
| Microbiota | 2 | 2021 | 392 | 0.620 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2024 | 630 | 0.540 |
Why?
|
| Polymerase Chain Reaction | 10 | 2009 | 1592 | 0.540 |
Why?
|
| DNA-Binding Proteins | 10 | 2021 | 2042 | 0.520 |
Why?
|
| Cell Differentiation | 6 | 2015 | 1935 | 0.490 |
Why?
|
| Mutation | 11 | 2017 | 5776 | 0.480 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 668 | 0.450 |
Why?
|
| Microsatellite Repeats | 6 | 2011 | 218 | 0.450 |
Why?
|
| Mice | 18 | 2024 | 17568 | 0.440 |
Why?
|
| Nuclear Proteins | 9 | 2012 | 1283 | 0.430 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2009 | 137 | 0.430 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2013 | 1000 | 0.430 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 483 | 0.430 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2009 | 469 | 0.410 |
Why?
|
| Intestinal Mucosa | 6 | 2015 | 768 | 0.400 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2013 | 1003 | 0.390 |
Why?
|
| Cell Line, Tumor | 21 | 2014 | 3293 | 0.380 |
Why?
|
| Intestines | 1 | 2015 | 576 | 0.380 |
Why?
|
| Stem Cells | 1 | 2015 | 710 | 0.360 |
Why?
|
| Neoplasm Proteins | 6 | 2009 | 670 | 0.350 |
Why?
|
| Gene Expression Profiling | 8 | 2010 | 1674 | 0.330 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 4 | 2015 | 126 | 0.320 |
Why?
|
| DNA, Neoplasm | 8 | 2009 | 303 | 0.310 |
Why?
|
| Transcription, Genetic | 5 | 2021 | 1703 | 0.310 |
Why?
|
| DNA Modification Methylases | 4 | 2021 | 43 | 0.300 |
Why?
|
| Animals | 19 | 2024 | 33755 | 0.300 |
Why?
|
| Azacitidine | 6 | 2009 | 56 | 0.300 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2021 | 559 | 0.290 |
Why?
|
| Humans | 68 | 2024 | 122432 | 0.290 |
Why?
|
| Fluorouracil | 1 | 2007 | 140 | 0.290 |
Why?
|
| Neoplasms | 9 | 2021 | 2753 | 0.280 |
Why?
|
| Folic Acid | 3 | 2024 | 291 | 0.280 |
Why?
|
| Lung Neoplasms | 5 | 2020 | 1614 | 0.280 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2009 | 713 | 0.280 |
Why?
|
| Colon | 5 | 2010 | 349 | 0.280 |
Why?
|
| Biomarkers, Tumor | 6 | 2010 | 1424 | 0.270 |
Why?
|
| Histones | 7 | 2021 | 530 | 0.270 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 2 | 2005 | 20 | 0.270 |
Why?
|
| Temperature | 1 | 2007 | 304 | 0.260 |
Why?
|
| Long Interspersed Nucleotide Elements | 4 | 2010 | 35 | 0.260 |
Why?
|
| Adenoma | 4 | 2010 | 134 | 0.250 |
Why?
|
| Gene Expression Regulation | 3 | 2010 | 2535 | 0.240 |
Why?
|
| Melanoma | 2 | 2009 | 835 | 0.230 |
Why?
|
| Genome, Human | 4 | 2011 | 1257 | 0.220 |
Why?
|
| Sulfites | 4 | 2014 | 30 | 0.220 |
Why?
|
| Kidney Neoplasms | 1 | 2007 | 426 | 0.220 |
Why?
|
| Sequence Analysis, DNA | 7 | 2014 | 1758 | 0.220 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 803 | 0.220 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2003 | 7 | 0.220 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 717 | 0.220 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2003 | 30 | 0.210 |
Why?
|
| Antineoplastic Agents | 4 | 2010 | 1680 | 0.210 |
Why?
|
| Lysine | 4 | 2008 | 201 | 0.210 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 90 | 0.210 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2002 | 64 | 0.210 |
Why?
|
| Aged | 21 | 2020 | 18785 | 0.210 |
Why?
|
| Cyclins | 1 | 2002 | 104 | 0.200 |
Why?
|
| B7-H1 Antigen | 1 | 2023 | 102 | 0.200 |
Why?
|
| Male | 35 | 2024 | 59590 | 0.200 |
Why?
|
| Epigenomics | 2 | 2021 | 163 | 0.200 |
Why?
|
| Liver | 1 | 2009 | 1851 | 0.200 |
Why?
|
| Middle Aged | 26 | 2012 | 25641 | 0.190 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2009 | 957 | 0.190 |
Why?
|
| Diet | 2 | 2024 | 1106 | 0.190 |
Why?
|
| Antimetabolites, Antineoplastic | 3 | 2007 | 178 | 0.190 |
Why?
|
| Aging | 3 | 2017 | 1165 | 0.190 |
Why?
|
| Genome | 2 | 2021 | 472 | 0.180 |
Why?
|
| Female | 33 | 2024 | 64958 | 0.180 |
Why?
|
| Cell Cycle | 1 | 2003 | 619 | 0.180 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 2 | 2012 | 5 | 0.180 |
Why?
|
| Dysbiosis | 1 | 2021 | 119 | 0.170 |
Why?
|
| Environmental Exposure | 1 | 2002 | 217 | 0.170 |
Why?
|
| Infant Nutrition Disorders | 1 | 2019 | 28 | 0.170 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 548 | 0.160 |
Why?
|
| Duodenum | 1 | 2019 | 100 | 0.160 |
Why?
|
| Celiac Disease | 1 | 2019 | 70 | 0.160 |
Why?
|
| Machine Learning | 1 | 2020 | 207 | 0.150 |
Why?
|
| Cell Line | 5 | 2013 | 2786 | 0.150 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 2 | 2015 | 24 | 0.150 |
Why?
|
| Aged, 80 and over | 10 | 2012 | 6289 | 0.150 |
Why?
|
| Base Sequence | 8 | 2011 | 3113 | 0.150 |
Why?
|
| Hedgehog Proteins | 2 | 2015 | 192 | 0.140 |
Why?
|
| Adenocarcinoma | 3 | 2009 | 1001 | 0.140 |
Why?
|
| Malnutrition | 1 | 2019 | 196 | 0.140 |
Why?
|
| Adult | 17 | 2014 | 28757 | 0.140 |
Why?
|
| Phenotype | 8 | 2010 | 4214 | 0.130 |
Why?
|
| Animals, Suckling | 1 | 2015 | 50 | 0.130 |
Why?
|
| Aurora Kinase C | 1 | 2015 | 4 | 0.130 |
Why?
|
| Brain Neoplasms | 1 | 2024 | 1222 | 0.120 |
Why?
|
| Liver Neoplasms | 3 | 2011 | 1386 | 0.120 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2010 | 542 | 0.120 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2014 | 31 | 0.120 |
Why?
|
| Adipose Tissue, Brown | 1 | 2015 | 76 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 1296 | 0.120 |
Why?
|
| Methylation | 2 | 2013 | 229 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2007 | 204 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2010 | 532 | 0.110 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2013 | 44 | 0.110 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2013 | 58 | 0.110 |
Why?
|
| CCCTC-Binding Factor | 1 | 2013 | 19 | 0.110 |
Why?
|
| Genes, Neoplasm | 3 | 2008 | 79 | 0.110 |
Why?
|
| Rectum | 2 | 2010 | 97 | 0.110 |
Why?
|
| Testis | 1 | 2015 | 407 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 5 | 2010 | 1076 | 0.100 |
Why?
|
| Chromatin | 3 | 2021 | 552 | 0.100 |
Why?
|
| Sequence Alignment | 1 | 2014 | 615 | 0.100 |
Why?
|
| Chromosome Mapping | 3 | 2014 | 1067 | 0.100 |
Why?
|
| Hypothalamus | 1 | 2013 | 213 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2017 | 2313 | 0.100 |
Why?
|
| Algorithms | 2 | 2020 | 1576 | 0.100 |
Why?
|
| Organ Specificity | 2 | 2010 | 427 | 0.100 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2012 | 368 | 0.090 |
Why?
|
| DNA Repair Enzymes | 2 | 2008 | 40 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2009 | 75 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 2581 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2008 | 2829 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 192 | 0.090 |
Why?
|
| Retinoblastoma Protein | 2 | 2008 | 76 | 0.090 |
Why?
|
| Frameshift Mutation | 1 | 2011 | 175 | 0.090 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2007 | 65 | 0.090 |
Why?
|
| Retroelements | 1 | 2010 | 41 | 0.090 |
Why?
|
| Apoptosis | 2 | 2007 | 1791 | 0.090 |
Why?
|
| Repressor Proteins | 2 | 2013 | 812 | 0.090 |
Why?
|
| Inflammation | 1 | 2017 | 1392 | 0.090 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 3869 | 0.090 |
Why?
|
| Biomarkers | 1 | 2019 | 2933 | 0.090 |
Why?
|
| Disease-Free Survival | 2 | 2009 | 872 | 0.090 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2010 | 49 | 0.090 |
Why?
|
| Hydroxamic Acids | 2 | 2007 | 56 | 0.090 |
Why?
|
| DNA Primers | 5 | 2010 | 668 | 0.090 |
Why?
|
| Genetics, Medical | 1 | 2010 | 117 | 0.090 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2009 | 67 | 0.090 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2009 | 32 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 4367 | 0.080 |
Why?
|
| alpha-Fetoproteins | 1 | 2010 | 136 | 0.080 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 179 | 0.080 |
Why?
|
| Butyrates | 1 | 2009 | 35 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2010 | 335 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2009 | 262 | 0.080 |
Why?
|
| Neoplasm Staging | 2 | 2009 | 1227 | 0.080 |
Why?
|
| Sp3 Transcription Factor | 1 | 2008 | 7 | 0.080 |
Why?
|
| Pleural Neoplasms | 1 | 2009 | 62 | 0.080 |
Why?
|
| ras Proteins | 2 | 2008 | 135 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 865 | 0.080 |
Why?
|
| Genes, APC | 1 | 2008 | 13 | 0.080 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 43 | 0.080 |
Why?
|
| Breast Neoplasms | 4 | 2008 | 2480 | 0.080 |
Why?
|
| Mesothelioma | 1 | 2009 | 77 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2008 | 156 | 0.080 |
Why?
|
| Centrosome | 1 | 2008 | 30 | 0.080 |
Why?
|
| Colitis | 1 | 2010 | 153 | 0.080 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 298 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2017 | 4511 | 0.080 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2008 | 6 | 0.080 |
Why?
|
| Polymorphism, Genetic | 2 | 2008 | 805 | 0.080 |
Why?
|
| Chromosomal Instability | 1 | 2008 | 57 | 0.080 |
Why?
|
| Tumor Protein p73 | 1 | 2007 | 21 | 0.080 |
Why?
|
| Prostate | 2 | 2008 | 422 | 0.080 |
Why?
|
| Drug Tolerance | 1 | 2007 | 40 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2012 | 2587 | 0.070 |
Why?
|
| Leucovorin | 1 | 2007 | 50 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2007 | 97 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2009 | 2010 | 0.070 |
Why?
|
| Survival Rate | 2 | 2009 | 1997 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2009 | 4655 | 0.070 |
Why?
|
| Sulfates | 1 | 2007 | 33 | 0.070 |
Why?
|
| Dinucleoside Phosphates | 1 | 2006 | 11 | 0.070 |
Why?
|
| Enzyme Inhibitors | 3 | 2009 | 582 | 0.070 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2008 | 154 | 0.070 |
Why?
|
| Receptors, Estrogen | 2 | 2009 | 788 | 0.070 |
Why?
|
| Multigene Family | 1 | 2007 | 299 | 0.070 |
Why?
|
| Genomic Imprinting | 1 | 2007 | 123 | 0.070 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 190 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 261 | 0.070 |
Why?
|
| Cisplatin | 1 | 2007 | 255 | 0.070 |
Why?
|
| MutL Protein Homolog 1 | 4 | 2008 | 54 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 2009 | 287 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2006 | 42 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2006 | 99 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2008 | 702 | 0.060 |
Why?
|
| Lymphocytes | 1 | 2007 | 403 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2007 | 1104 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 1034 | 0.060 |
Why?
|
| ErbB Receptors | 1 | 2006 | 282 | 0.060 |
Why?
|
| Prostatic Neoplasms | 3 | 2008 | 1516 | 0.060 |
Why?
|
| Microarray Analysis | 3 | 2010 | 231 | 0.060 |
Why?
|
| X-linked Nuclear Protein | 1 | 2024 | 16 | 0.060 |
Why?
|
| Logistic Models | 2 | 2020 | 1772 | 0.060 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2024 | 55 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2012 | 282 | 0.060 |
Why?
|
| Colitis, Ulcerative | 1 | 2007 | 211 | 0.060 |
Why?
|
| Genes, ras | 2 | 2017 | 96 | 0.060 |
Why?
|
| Telomerase | 1 | 2024 | 165 | 0.060 |
Why?
|
| Disease Progression | 4 | 2014 | 1990 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2010 | 839 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2003 | 15 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2024 | 187 | 0.050 |
Why?
|
| Genes, p53 | 3 | 2009 | 215 | 0.050 |
Why?
|
| Stomach Neoplasms | 1 | 2009 | 536 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2003 | 76 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2009 | 12041 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2002 | 86 | 0.050 |
Why?
|
| Receptors, Progesterone | 1 | 2007 | 865 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2008 | 525 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 217 | 0.050 |
Why?
|
| Sample Size | 1 | 2002 | 79 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 515 | 0.050 |
Why?
|
| Aflatoxins | 1 | 2002 | 2 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2002 | 143 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2002 | 138 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2006 | 706 | 0.050 |
Why?
|
| Risk Factors | 3 | 2009 | 9901 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 802 | 0.050 |
Why?
|
| Hepatitis | 1 | 2002 | 65 | 0.050 |
Why?
|
| Prognosis | 3 | 2010 | 4489 | 0.050 |
Why?
|
| Carcinogens | 1 | 2002 | 152 | 0.050 |
Why?
|
| Gene Ontology | 1 | 2021 | 47 | 0.050 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 36 | 0.050 |
Why?
|
| Adolescent | 5 | 2010 | 18970 | 0.050 |
Why?
|
| Molecular Sequence Annotation | 1 | 2021 | 145 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2021 | 222 | 0.050 |
Why?
|
| Fibrosis | 1 | 2002 | 428 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2006 | 689 | 0.040 |
Why?
|
| Child | 4 | 2024 | 24105 | 0.040 |
Why?
|
| Pluripotent Stem Cells | 2 | 2010 | 76 | 0.040 |
Why?
|
| Pakistan | 1 | 2019 | 75 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2011 | 793 | 0.040 |
Why?
|
| Young Adult | 2 | 2010 | 8778 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2003 | 1468 | 0.040 |
Why?
|
| Growth | 1 | 2019 | 107 | 0.040 |
Why?
|
| Patient Selection | 1 | 2002 | 685 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 3073 | 0.040 |
Why?
|
| Cause of Death | 1 | 2020 | 451 | 0.040 |
Why?
|
| Colonic Polyps | 2 | 2010 | 78 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2009 | 239 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2007 | 3307 | 0.040 |
Why?
|
| LIM Domain Proteins | 2 | 2008 | 59 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2019 | 209 | 0.040 |
Why?
|
| Karyotyping | 2 | 2008 | 338 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2019 | 297 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2009 | 160 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2009 | 3229 | 0.040 |
Why?
|
| Wnt Proteins | 2 | 2008 | 201 | 0.040 |
Why?
|
| RNA, Untranslated | 2 | 2009 | 114 | 0.040 |
Why?
|
| Infant | 3 | 2019 | 12334 | 0.040 |
Why?
|
| HCT116 Cells | 2 | 2007 | 55 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2010 | 1568 | 0.030 |
Why?
|
| Acetylation | 2 | 2008 | 168 | 0.030 |
Why?
|
| Research Design | 1 | 2019 | 646 | 0.030 |
Why?
|
| Carrier Proteins | 3 | 2007 | 1020 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2010 | 5013 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1246 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 2 | 2010 | 444 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2015 | 27 | 0.030 |
Why?
|
| RNA, Long Noncoding | 2 | 2009 | 210 | 0.030 |
Why?
|
| Cilia | 1 | 2015 | 73 | 0.030 |
Why?
|
| Homeodomain Proteins | 2 | 2009 | 546 | 0.030 |
Why?
|
| COUP Transcription Factor II | 1 | 2015 | 117 | 0.030 |
Why?
|
| Texas | 1 | 2002 | 3528 | 0.030 |
Why?
|
| Precipitin Tests | 2 | 2004 | 153 | 0.030 |
Why?
|
| Age Factors | 2 | 2010 | 2777 | 0.030 |
Why?
|
| Genomics | 2 | 2014 | 1472 | 0.030 |
Why?
|
| beta Catenin | 1 | 2014 | 208 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1678 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2011 | 2797 | 0.030 |
Why?
|
| Time Factors | 1 | 2003 | 6181 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 873 | 0.030 |
Why?
|
| Genotype | 1 | 2018 | 2533 | 0.020 |
Why?
|
| 5-Methylcytosine | 1 | 2012 | 32 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2012 | 62 | 0.020 |
Why?
|
| Dioxygenases | 1 | 2012 | 46 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2010 | 1526 | 0.020 |
Why?
|
| Gambia | 1 | 2010 | 28 | 0.020 |
Why?
|
| Transgenes | 1 | 2012 | 330 | 0.020 |
Why?
|
| Fertilization | 1 | 2010 | 43 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 109 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2010 | 85 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 239 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2010 | 50 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 1007 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 99 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2010 | 57 | 0.020 |
Why?
|
| Tretinoin | 1 | 2010 | 117 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2009 | 35 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2009 | 58 | 0.020 |
Why?
|
| Vitamin B 6 | 1 | 2009 | 11 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 120 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2018 | 13817 | 0.020 |
Why?
|
| Seasons | 1 | 2010 | 300 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 288 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2008 | 32 | 0.020 |
Why?
|
| Rural Population | 1 | 2010 | 243 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 92 | 0.020 |
Why?
|
| Protein Methyltransferases | 1 | 2008 | 9 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 319 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 172 | 0.020 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2008 | 28 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2008 | 70 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 115 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2008 | 50 | 0.020 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2008 | 57 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2008 | 96 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2009 | 159 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 356 | 0.020 |
Why?
|
| Urothelium | 1 | 2008 | 60 | 0.020 |
Why?
|
| Clone Cells | 1 | 2008 | 167 | 0.020 |
Why?
|
| Bias | 1 | 2008 | 113 | 0.020 |
Why?
|
| Methyltransferases | 1 | 2008 | 67 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2007 | 18 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 576 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 707 | 0.020 |
Why?
|
| Aspirin | 1 | 2009 | 222 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 460 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 552 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2007 | 31 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2007 | 13 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2007 | 125 | 0.020 |
Why?
|
| Remission Induction | 1 | 2007 | 301 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4285 | 0.020 |
Why?
|
| K562 Cells | 1 | 2007 | 95 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 1004 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2007 | 24 | 0.020 |
Why?
|
| Friedreich Ataxia | 1 | 2007 | 47 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 2006 | 189 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2008 | 242 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2009 | 239 | 0.020 |
Why?
|
| Telomere | 1 | 2008 | 205 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2009 | 336 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2007 | 112 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2007 | 136 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2006 | 45 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2007 | 82 | 0.020 |
Why?
|
| Life Style | 1 | 2009 | 394 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 768 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2019 | 8108 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2006 | 7 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 278 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2008 | 343 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2009 | 333 | 0.020 |
Why?
|
| Cadherins | 1 | 2007 | 164 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 2006 | 85 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 353 | 0.020 |
Why?
|
| Quinazolines | 1 | 2006 | 176 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2007 | 398 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2007 | 755 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 663 | 0.020 |
Why?
|
| Mesoderm | 1 | 2006 | 117 | 0.020 |
Why?
|
| Binding Sites | 1 | 2008 | 1293 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 751 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2009 | 460 | 0.020 |
Why?
|
| Computational Biology | 1 | 2010 | 794 | 0.020 |
Why?
|
| Leukemia | 1 | 2008 | 375 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 568 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 1413 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1873 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 579 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 1070 | 0.010 |
Why?
|
| Neurons | 1 | 2013 | 1920 | 0.010 |
Why?
|
| Smoking | 1 | 2009 | 1028 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 414 | 0.010 |
Why?
|
| DNA Repair | 1 | 2007 | 584 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2005 | 597 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 1090 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1679 | 0.010 |
Why?
|
| Palliative Care | 1 | 2006 | 424 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 3075 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 1370 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1710 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 3658 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2006 | 907 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 1114 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 5962 | 0.010 |
Why?
|
| Quality of Life | 1 | 2006 | 1913 | 0.010 |
Why?
|